13F Insight
DOSSIER · 13F-HR · Q1 2026

Ally Bridge Group (NY) LLC

$124M in tracked AUM across 28 positions as of Q1 2026.

AB
CIK 0001822947 · last filed Mar 31, 2026
Total AUM
$124M
as of Q1 2026
Holdings
28
—
positions
Whale Score
56
56
tracked
Activity
—
no data
changes this Q
AI Analysis · Q1 2026

Ally Bridge Group (NY) LLC filed its latest 13F-HR for Q1 2026. See the latest holdings and position changes below.

Quarter at a glance — Q1 2026

Position-change comparison pending.

No quarter-over-quarter changes available.

Top 10 holdings

By portfolio weight as of Q1 2026.

#HoldingValueSharesWeight
01
SLNO
SOLENO THERAPEUTICS INC
$13M400K10.8%02
PRAX
PRAXIS PRECISION MEDICINES I
$11M33K8.5%03
NERV
MINERVA NEUROSCIENCES INC
$10M1.7M8.1%04
OVID
OVID THERAPEUTICS INC
$6M2.8M5.1%05
CMPS
COMPASS PATHWAYS PLC
$6M1.0M4.7%06
TARS
TARSUS PHARMACEUTICALS INC
$6M81K4.6%07
SLDB
SOLID BIOSCIENCES INC
$6M767K4.5%08
CMPX
COMPASS THERAPEUTICS INC
$5M1.0M4.3%09
74346M505
PROMIS NEUROSCIENCES INC
$5M414K4.2%10
EWTX
EDGEWISE THERAPEUTICS INC
$5M161K4.1%

Filing history

2026Q1Mar 31
$124M▲ 29.0%
28 positionsView →2025Q4Dec 31
$96M▼ 3.7%
20 positionsView →2025Q3Sep 30
$100M▼ 17.1%
18 positionsView →2025Q2Jun 30
$120M▲ 80.8%
24 positionsLocked2025Q1Mar 31
$66M▼ 43.0%
17 positionsLocked2024Q4Dec 31
$117M▼ 37.6%
30 positionsLocked2024Q3Sep 30
$187M▲ 11.3%
29 positionsLocked2024Q2Jun 30
$168M▼ 6.7%
25 positionsLocked2024Q1Mar 31
$180M▲ 7.2%
22 positionsLocked2023Q4Dec 31
$168M▲ 97.0%
22 positionsLocked2023Q3Sep 30
$85M▲ 3.2%
19 positionsLocked2023Q2Jun 30
$83M▲ 8.2%
17 positionsLocked
Showing 12 of 22